|
MKKS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62470037423645E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
7.735900E-02 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
2.127399999996E-05 |
| Stage1-vs-Stage3 |
5.576000E-02 |
| Stage1-vs-Stage4 |
5.55679999999503E-05 |
| Stage2-vs-Stage3 |
6.25550000021846E-07 |
| Stage2-vs-Stage4 |
2.9883000518538E-09 |
| Stage3-vs-Stage4 |
5.586200E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.72259999492641E-08 |
| Normal-vs-Asian |
7.84440290502175E-11 |
| Caucasian-vs-AfricanAmerican |
9.698800E-01 |
| Caucasian-vs-Asian |
1.526970E-01 |
| AfricanAmerican-vs-Asian |
4.183000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88737914186277E-15 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
5.139000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
5.24025267623074E-14 |
| Normal-vs-Age(61-80Yrs) |
2.43739994854053E-09 |
| Normal-vs-Age(81-100Yrs) |
1.015790E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.981400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.470300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.435200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.451800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.076200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.376000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.51080037369411E-10 |
| Classical-VS-Follicular |
8.98999763521147E-11 |
| Classical-VS-Other |
3.783200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.62447832963153E-12 |
| Tall-VS-Other |
2.911400E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
6.315200E-03 |
| Follicular-VS-Normal |
1.055630E-02 |
| Other-VS-Normal |
1.56261999999519E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.03829952916124E-10 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
4.03620026290241E-10 |
|
|
